# Postoperative Basal Bolus or Sliding Scale Insulin Regimen in DM2 and Its Effect on Surgical Site Infections.

> **NCT06638567** · NA · RECRUITING · sponsor: **Abraham Hulst, MD, PhD** · enrollment: 1008 (estimated)

## Conditions studied

- Diabetes Mellitus, Type 2
- Surgical Site Infection

## Interventions

- **OTHER:** Basal bolus insulin regimen

## Key facts

- **NCT ID:** NCT06638567
- **Lead sponsor:** Abraham Hulst, MD, PhD
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-03
- **Primary completion:** 2027-02
- **Final completion:** 2027-09
- **Target enrollment:** 1008 (ESTIMATED)
- **Last updated:** 2025-01-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06638567

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06638567, "Postoperative Basal Bolus or Sliding Scale Insulin Regimen in DM2 and Its Effect on Surgical Site Infections.". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06638567. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*